Free Trial

NEXGEL Q1 2024 Earnings Report

NEXGEL logo
$3.37 -0.13 (-3.71%)
As of 01/21/2025 04:00 PM Eastern

NEXGEL EPS Results

Actual EPS
-$0.14
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NEXGEL Revenue Results

Actual Revenue
$1.27 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NEXGEL Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

NEXGEL Earnings Headlines

The #1 Stock for Trump’s Second Term?
Imagine how much money you could make if you bought all of the top performing stocks during Trump's second term? Well, legendary investor Louis Navellier's stock rating system... Gave a buy rating to ALL of the top 30 performing stocks in the S&P 500 index of Trump's first term...
NEXGEL Appoints Joseph McGuire To Succeed Adam Drapczuk III As CFO
NexGel appoints McGuire as Chief Financial Officer
See More NEXGEL Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NEXGEL? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NEXGEL and other key companies, straight to your email.

About NEXGEL

NEXGEL (NASDAQ:NXGL) manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

View NEXGEL Profile

More Earnings Resources from MarketBeat